Company Performance Metrics
CanceRNA Biotechnology provides laboratory and consultancy services focused on chemical characterization and toxicological risk assessment for medical devices under the European Union Medical Device Regulation. The company conducts ISO 10993-18 studies to characterize materials and leachables and ISO 10993-17 evaluations to determine acceptable
limits for extractable substances. Its team uses a wide range of spectroscopic, chromatographic, thermal, surface and elemental analysis techniques to support biocompatibility assessments and documentation. CanceRNA Biotechnology also performs chemical equivalence testing for medical device raw materials and processes. In addition, it supplies chemical consumables, laboratory equipment and complete laboratory setups for international projects and institutions. The company exports both analytical services and laboratory procurement solutions to organizations in the medical and life science sectors.
